We are live on ! Find out more
LCTX icon

Lineage Cell Therapeutics

56 hedge funds and large institutions have $63.8M invested in Lineage Cell Therapeutics in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.84% less ownership

Funds ownership: 36.82%35.98% (-0.84%)

3% less capital invested

Capital invested by funds: $65.6M → $63.8M (-$1.78M)

3% less funds holding

Funds holding: 5856 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

69% less call options, than puts

Call options by funds: $202K | Put options by funds: $654K

Holders
56
Holders Change
-2
Holders Change %
-3.45%
% of All Funds
1.82%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
25
Reduced
9
Closed
6
Calls
$202K
Puts
$654K
Net Calls
-$452K
Net Calls Change
+$127K